Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01856049 · ClinicalTrials.gov registry record · NA
Umbilical Cord Blood Collection and Processing for Hypoplastic Left Heart Syndrome Patients
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 464
- Enrollment target
NCT01856049: Completed NA study, sponsored by Mayo Clinic.
NCT01856049 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 464 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01856049, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 464 participants
- Enrollment target
Study Summary
Cell-based cardiac regeneration has been the focus of acquired, adult heart disease for many years. However, congenital heart disease with severe structural abnormalities may also be reasonable targets for cell-based therapies. Interestingly, the pediatric heart is naturally growing and may be the most amendable to regenerative strategies. Therefore, identifying autologous cells (cells from the patient's own body) would be important to initiate these studies. This study aims to validate the use of umbilical cord blood as a source of autologous cells for the purpose of cardiac repair of congenital heart disease. Cells will be isolated from the cord blood to help us determine the feasibility of collection, processing, and storage of these samples at the time of birth of infants with prenatal diagnosis of hypoplastic left heart syndrome. This study may be useful for the development of pre-clinical and clinical studies aimed at the long-term goal of repairing damaged heart muscle.
Interventions
- OTHER Collection of umbilical cord blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 464 participants |
| Start Date | 2012-05 |
| Est. Completion | 2024-11-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01856049
The ClinicalTrials.gov registry entry for NCT01856049 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 464 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Collection of umbilical cord blood is the first listed.
NCT01856049 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01856049 about?
NCT01856049 is a clinical study titled "Umbilical Cord Blood Collection and Processing for Hypoplastic Left Heart Syndrome Patients". Cell-based cardiac regeneration has been the focus of acquired, adult heart disease for many years. However, congenital heart disease with severe structural abnormalities may also be reasonable targets for cell-based therapies. Interestingly, the pediatric heart is naturally growing and may be the m...
What is the current status of trial NCT01856049?
This trial is currently completed. It is a NA study. The enrollment target is 464 participants. The study started on 2012-05. Estimated completion is 2024-11-12.
What interventions are being tested in trial NCT01856049?
The interventions under investigation include: Collection of umbilical cord blood (OTHER).
Who is sponsoring clinical trial NCT01856049?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.